`The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though some of these challenges may seem insurmountable, the glimmer of hope always exists that could rejuvenate the IVD industry over the coming years. Improvement in healthcare infrastructure, growth in personalized medicine based on bespoke solutions and companies’ focus towards growth-centric emerging markets certainly constitute some of the major factors that can be looked up to.
The arrival of novel technologies and innovations has spawned assays and biomarkers that would play crucial roles in the high-growth areas of infectious diseases, women’s health, cancer and cardiovascular conditions. Molecular diagnostics and the genomic reform have been the primary drivers of this growth, which are expected to sustain this level not only by tailoring existing drug therapies for individual patients, but also through developing new drug therapies that would enable in the better identification of patient populations that could prospectively benefit from drug treatment. Companies would do well to concentrate on tests based on biomarkers, such as those utilizing protein-based biomarkers for Alzheimer’s disease, and the genomic revolution, with solutions using gene-based testing for indicating the probability of a range of cancers.
Though it may seem that the IVD industry is at a vital crossroad, looking hither and thither, the key point remains focusing on the above-mentioned areas to garner adequate standing that would enable in a complete turnaround. Personalized medicine appears to be a crucial aspect that has to be looked into with detail, so as to ascertain where the future of this industry lies.
The report reviews, analyses and projects IVD market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 22 independent countries across North America – United States, Canada and Mexico; Europe – Western Europe (Germany, France, Italy, Spain, United Kingdom, Belgium, Netherlands, Switzerland, Portugal, Austria, Greece, Scandinavia and Rest of Western Europe) and Eastern Europe (Poland, Czech Republic, Russia and Rest of Eastern); Asia-Pacific –Japan, China, India and Rest of Asia-Pacific; South America – Argentina, Brazil and Rest of South America; and Rest of World.
Market for IVD product categories analyzed in this study includes Reagents & Consumables and Instruments & Systems. The report also includes the market analysis for end-use application analysis of IVDs – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology.
This 493 page global market report includes 284 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product category and application area. The report comprises the brief business profiles of 47 key global players and 60 major players across the United States – 36; Europe – 18; and Asia-Pacific – 6. The report also provides the listing of the companies engaged in research and development, equipment manufacturing, processing, supplies and distribution of In Vitro Diagnostics. The global list covers the addresses, contact numbers and the website addresses of 382 companies.
Global In Vitro Diagnostic Industry
TABLE OF CONTENTS:
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
1.1 Product Outline
1.1.1 Positives
1.1.2 Precision of IVDs
1.1.3 Type of Products Used For In Vitro Diagnostics
1.1.3.1 General Purpose Reagents
1.1.3.2 Analyte Specific Reagents
1.1.3.3 Biochemical and Chemical Reagents: An Overview
1.1.3.3.1 Opting for the Optimal Biochemical and Chemical Reagents for IVD Tests
2. A SNAPSHOT OF END-USE APPLICATIONS
2.1 Clinical Chemistry
2.1.1 Clinical Chemistry Analyzers
2.2 Immunoassays
2.2.1 Objective of Immunoassays
2.2.2 Immunoassay Methodologies
2.3 Diabetes Testing
2.3.1 Primary Types of Diabetes
2.3.2 Prediabetes
2.3.3 Diagnosis of Diabetes and Prediabetes
2.3.3.1 Fasting Plasma Glucose (FPG) Test
2.3.3.2 Oral Glucose Tolerance Test (OGTT)
2.3.3.3 Random Plasma Glucose Test
2.4 Blood Testing
2.4.1 Categories of Blood Tests
2.4.1.1 Complete Blood Count (CBC)
2.4.1.2 Red Blood Cells
2.4.1.3 White Blood Cells
2.4.1.4 Platelets
2.4.1.5 Hemoglobin
2.4.1.6 Hematocrit
2.4.1.7 Mean Corpuscular Volume (MCV)
2.4.2 Blood Chemistry Tests/Biochemical Analysis
2.5 Molecular Diagnostics
2.5.1 Molecular Diagnostics Techniques
2.5.2 Molecular Diagnostics and Genome Research
2.5.3 Molecular Diagnostics Tools
2.5.3.1 Sample Collection and Preparation
2.5.3.2 Amplification and Detection Platforms and Assays
2.5.3.3 Software Tools
2.5.3.4 Complete Solutions
2.5.4 What the Future Holds for Molecular Tools
2.6 Pathology
2.6.1 Anatomical Pathology
2.6.2 Chemical Pathology
2.6.3 Clinical Pathology
2.6.4 Forensic Pathology
2.6.5 General Pathology
2.6.6 Genetic Pathology
2.6.7 Hematology Pathology
2.6.8 Immunopathology
2.6.9 Microbiology
2.7 Microbiology
3. KEY MARKET TRENDS
Glucose Levels to be Measured via Breath with New Diabetes Device
New Technology to Protect Insulin in Africa
Depressed? Get a Blood Test
3-D Microscopy Assistance for Cell Analysis
Bacteria-Based Test Strips for Detecting Glucose Levels in Diabetics in the Offing
Mid-2012 Set Timeline for FDA for Issuing Final Guidance for In Vitro Companion Diagnostics
- The 2011 Draft Guidance
- Companion Diagnostic Tests
Diabetes Testing Made Easier with New Technology
In-Vitro Nanodiagnostics to Detect Pathogens: Contemporary Trends
Clinical Laboratories Offer Physicians New Diagnostic Technology for Speedier and Better Diagnosis
New Blood Test to Detect Alzheimer's Five Years Beforehand
Early Diagnosis of Cryptococcosis Aided by New Rapid Blood Test
Diagnosis of Mesothelioma Could be Done Earlier with New Blood Test
Challenges Confronting Western Europe’s In Vitro Diagnostics Industry and Probable Solutions
- Introduction
- Challenges Faced by the Industry
- What the Industry Needs to Accomplish
“Cry” for Measuring Blood Glucose Levels
Diabetes Care Alleviated with New Tool that Saves Time and Reduces Error Risks
Future Role of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
- Introduction
- Metabolomic Profiling in Clinical Medicine
Diagnosing Heart Attacks with a New Blood Test
- Problems Associated with Paucity in Diagnostic Tests
- Prognosis
Genome Wide Association Study in South Asia Reveals New Genes Related to Diabetes
Field-Based Molecular Diagnostic Test for African Sleeping Sickness on the Horizon
Enhancing Type 2 Diabetes Therapies with Mobile Phone Technology
Prostate Cancer Detection to be Improved with New ‘Biomarker’ Blood Test
Regulation of Molecular Diagnostic Assays
Breast Cancer Detection via Blood Test and its Possibility
A Trouble-Free Blood Test for Detecting Lung Cancer
Blood Glucose Monitoring Advancements
- Watch Monitors
- Lifesaving Tattoos
- Contact Lenses
New Blood Test Technology for Detecting Alzheimer's Developed
Migrating Cancer Cells Perceived with New Blood Test
One Drop of Blood Required for Lab-On-A-Chip Device
New DNA Blood Test for Detecting Down’s Syndrome in Pregnant Women
New Molecular Diagnostic Technology for Cervical Cancer Developed by European Researchers
- Expression of Genes
- mRNA Detective
- The Major Challenge
Single-Cell Molecular 'Fingerprints' for Brain Tumors Generated using New Diagnostic Chip
In Vitro Diagnostics’ Initiatives in the Battle to Combat Heart Conditions
- IVD and Immunoassays
- Point-of-Care Technology
- Evolution of Cardiac Markers
- POC Immunoassay Platforms: What the Future Holds
4. KEY GLOBAL PLAYERS
3M Company
Abbott Laboratories, Inc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Alere Inc
Arkray, Inc.
B.R.A.H.M.S GmbH
Baxter International Inc.
Bayer AG
Beckman Coulter, Inc.
Becton, Dickinson And Company
BG Medicine, Inc.
Biocartis NV
bioMérieux SA
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Caliper Life Sciences, Inc.
Celera Corporation
Celgene Corporation
China Medical Technologies, Inc.
Covidien PLC
Danaher Corporation
EMD Millipore
F. Hoffmann-La Roche Ltd.
GE Healthcare Ltd.
Gen-Probe Incorporated
Hitachi Chemical Diagnostics
Johnson & Johnson
Kaneka Corporation
Merck KGaA
Meridian Bioscience, Inc.
MP Biomedicals LLC
Novartis AG
Novo Nordisk A/S
Olympus Corporation
Perkinelmer, Inc.
Pfizer Inc
Qiagen N.V.
Roche Diagnostics Corporation
Roche Holding Ltd.
Sekisui Diagnostics LLC
Shanghai Kehua Bio-Engineering
Siemens AG
Siemens Healthcare Diagnostics Inc.
Sigma-Aldrich Corporation
Thermo Fisher Scientific Inc.
5. KEY BUSINESS TRENDS
Abbott and Genetics Laboratory, Inc in an Agreement
Abbott and Merck in an Agreement
ARKRAY, Inc to Introduce SPOTCHEM™ CL SB-1440
Samsung Acquires Nexus division of ITC Nexus Holding Company
Affymetrix’s GeneChip® System 3000Dx v.2 for In Vitro Clinical Diagnostic Use Cleared by China’s State Food and Drug Administration
Roche, Life Technologies in Licensing Agreements
Abbott and University of North Texas (UNT) Health Science Center in Collaboration
Multifunctional Cholesterol Meter Device from Eternity Healthcare
Dako and Amgen Enter into an Agreement
miRInform Pancreas Test Introduced by Asuragen
VetScan Canine Lyme Rapid Test Launched by Abaxis
Siemens Forms Two New Companion Diagnostics Collaborations
Life Technologies and DaAn Gene Establish Chinese Joint Venture
Remote Glucose Monitor from Medtronic
Bionime to Offer GE-Branded Diabetes Solutions
QIAGEN Forms Two Agreements with US Biotech Companies
Agilent Technologies and Integrated Diagnostics in a Partnership
Micronics Taken Over by Sony
Enhanced Immunoassay Specificity and Accuracy from Thermo Fisher Scientific
In Vitro Diagnostic Test for Chagas Disease from Abbott
Proteome Sciences Unveils In Vitro Assays
Siemens, Illumina in an Alliance
Immunoassay Solution for Rapid Detection of Synthetic Cannabinoids from Randox
MultiGEN Diagnostics Acquired by TrovaGene
Life technologies in an Agreement with GlaxoSmithKline
3500 Dx Series Genetic Analyzers for In Vitro Diagnostics Introduced by Life Technologies in China
GE Commits US$1 Billion for Cancer R&D
Quidel Molecular Diagnostics Assays to be Distributed by Life Technologies in Europe
New Version of MicroRNA Screening Product from HTG Molecular Diagnostics
EMD Millipore Takes Over Amnis
QIAGEN and Pfizer Enter into Collaboration
IVD Reagents Portfolio from SDIX Expanded
SurModics® Assay Diluent (Protein-Free) Launched by SurModics
Siemens and JEOL in a Partnership
C. difficile GDH Immunoassay Launched by Pro-Lab Diagnostics
bioMérieux Takes Over ARGENE
mtm laboratories AG Taken Over by Roche
Labchip® Dx from Caliper Bestowed with CE IVD Mark
Apo B Antibody for the IVD Market Launched by SDIX
Seegene in Partnership with Samsung
Landmark Salmonella Detection Technology Introduced by bioMérieux
HealthMed Services Acquires DRS Technologies
Molecular Diagnostic Test for Detecting Food-Borne Pathogens from Veredus
Roche and Merck in Collaboration
Siemens’ IMMULITE 2000 XPi Immunoassay System Cleared by the USFDA
Myconostica Ltd Acquired by Lab21
Qiagen Acquires Cellestis
QIAGEN and Merck Collaborate with Government of Rwanda
Tecan and Sword Diagnostics Introduce a New Immunoassay Detection Technology
GeneChip® miRNA 2.0 Array Launched by Affymetrix
Novartis and Grifols in an Agreement to Commercialize Diagnostic Products
Biocartis, Janssen Pharmaceutica NV in a Molecular Diagnostics Partnership
J&J and Massachusetts General Hospital in Collaboration
bioMérieux, Philips Achieve a Landmark
Septin9 Blood Testing Service for Colorectal Cancer Launched by Warnex in Canada
bioMérieux, Biocartis in a Molecular Diagnostics Alliance
QIAGEN, Abbott in an Agreement
Abbott’s Enhanced FreeStyle Lite® Blood Glucose Test Strips Launched in Australia
New Automated Modular Testing Platform for Molecular Diagnostics from QIAGEN
cobas e 602 Immunoassay Module Launched by Roche
IH 1000 Automated Blood Screening System Launched by Bio-Rad
Philips’ Technology Platform for Automated DNA/RNA Molecular Diagnostic Testing Acquired by Biocartis
6. GLOBAL MARKET OVERVIEW
6.1 Market Overview by Product Type
6.2 Market overview by Application Area
6.3 IVD Product Type Overview by Geographic Region
6.3.1 IVD Reagents & Consumables
6.3.2 IVD Instruments & Systems
6.4 IVD Application Area Overview by Geographic Region
6.4.1 Clinical Chemistry
6.4.2 Immunoassay
6.4.3 Diabetes Testing
6.4.4 Blood Testing
6.4.5 Molecular Diagnostics
6.4.6 Pathology
6.4.7 Cellular Analysis
6.4.8 Microbiology
PART B: REGIONAL MARKET PERSPECTIVE
Developed Vs. Developing World
Can Recession be a Factor Worthy of Consideration?
Scenario in Hospitals
What is in Store
REGIONAL MARKET OVERVIEW
1. NORTH AMERICA
1.1 Market Overview by Geographic Region
1.2 Market Overview by Product Type
1.3 Market Overview by Application Area
1.4 IVD Product Type Overview by North American Region
1.4.1 Reagents & Consumables
1.4.2 Instruments & Systems
1.5 IVD Application Area Overview by North American Region
1.5.1 Clinical Chemistry
1.5.2 Immunoassay
1.5.3 Diabetes Testing
1.5.4 Blood Testing
1.5.5 Molecular Diagnostics
1.5.6 Pathology
1.5.7 Cellular Analysis
1.5.8 Microbiology
1.6 Major Market Players
3M Company (United States)
Abbott Diabetes Care, Inc. (United States)
Abbott Diagnostics Inc (United States)
Abbott Laboratories, Inc. (United States)
Abbott Molecular Inc. (United States)
Affymetrix, Inc. (United States)
Agilent Technologies, Inc. (United States)
Alere Inc (United States)
Baxter International Inc. (United States)
Beckman Coulter, Inc. (United States)
Becton, Dickinson And Company (United States)
BG Medicine, Inc. (United States)
Bio-Rad Laboratories, Inc. (United States)
Bristol-Myers Squibb Company (United States)
Caliper Life Sciences, Inc. (United States)
Celera Corporation (United States)
Celgene Corporation (United States)
Danaher Corporation (United States)
EMD Millipore (United States)
Gen-Probe Incorporated (United States)
Hitachi Chemical Diagnostics (United States)
Hologic Inc (United States)
Instrumentation Laboratory (United States)
Johnson & Johnson (United States)
Life Technologies Corporation (United States)
Meridian Bioscience, Inc. (United States)
MP Biomedicals LLC (United States)
Ortho-Clinical Diagnostics Inc. (United States)
Perkinelmer, Inc. (United States)
Pfizer Inc (United States)
Roche Diagnostics Corporation (United States)
Roche Molecular Systems Inc. (United States)
Sekisui Diagnostics LLC (United States)
Siemens Healthcare Diagnostics Inc. (United States)
Sigma-Aldrich Corporation (United States)
Thermo Fisher Scientific Inc. (United States)
1.7 North American Market Overview by Country
1.7.1 United States
1.7.1.1 Market Overview by Product Type
1.7.1.2 Market Overview by Application Area
1.7.2 Canada
1.7.2.1 Market Overview by Product Type
1.7.2.2 Market Overview Application Area
1.7.3 Mexico
1.7.3.1 Market Overview by Product Type
1.7.3.2 Market Overview Application Area
2. EUROPE
2.1 Market Overview by Geographic Region
2.2 Market Overview by Product Type
2.3 Market Overview by Application Area
2.4 Major Market Players
Axis-Shield Plc (United Kingdom)
B.R.A.H.M.S GmbH (Germany)
Bayer AG (Germany)
Bayer Healthcare AG (Germany)
Biocartis NV (Belgium)
bioMérieux SA (France)
Boehringer Ingelheim GmbH (Germany)
Covidien Plc (Ireland)
F. Hoffmann-La Roche Ltd. (Switzerland)
GE Healthcare Ltd. (United Kingdom)
Merck KGaA (Germany)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Qiagen N.V. (The Netherlands)
Roche Holding Ltd. (Switzerland)
Siemens AG (Germany)
Siemens Healthcare (Germany)
Trinity Biotech Plc (Ireland)
2.5 European Market Overview by Region
2.5.1 Western Europe
2.5.1.1 Market Overview by Geographic Region
2.5.1.2 Market Overview by Product Type
2.5.1.3 Market Overview by Application Area
2.5.1.4 IVD Product Type Overview by Western Europe Region
2.5.1.4.1 Reagents & Consumables
2.5.1.4.2 Instruments & Systems
2.5.1.5 IVD Application Area Overview by Western Europe Region
2.5.1.5.1 Clinical Chemistry
2.5.1.5.2 Immunoassay
2.5.1.5.3 Diabetes Testing
2.5.1.5.4 Blood Testing
2.5.1.5.5 Molecular Diagnostics
2.5.1.5.6 Pathology
2.5.1.5.7 Cellular Analysis
2.5.1.5.8 Microbiology
2.5.1.6 Western Europe Market Overview by Country
2.5.1.6.1 Germany
2.5.1.6.1.1 Market Overview by Product Type
2.5.1.6.1.2 Market Overview by Application Area
An Appraisal from the Recent Past
2.5.1.6.2 France
2.5.1.6.2.1 Market Overview by Product Type
2.5.1.6.2.2 Market Overview by Application Area
Recent Past: An Assessment
2.5.1.6.3 Italy
2.5.1.6.3.1 Market Overview by Product Type
2.5.1.6.3.2 Market Overview by Application Area
A Peek into the Recent Past
2.5.1.6.4 Spain
2.5.1.6.4.1 Market Overview by Product Type
2.5.1.6.4.2 Market Overview by Application Area
What the Recent Past Revealed and its Future Effect
2.5.1.6.5 The United Kingdom
2.5.1.6.5.1 Market Overview by Product Type
2.5.1.6.5.2 Market Overview by Application Area
The United Kingdom’s Past, Current and Future IVD Trends
2.5.1.6.6 Belgium
2.5.1.6.6.1 Market Overview by Product Type
2.5.1.6.6.2 Market Overview by Application Area
2.5.1.6.7 The Netherlands
2.5.1.6.7.1 Market Overview by Product Type
2.5.1.6.7.2 Market Overview by Application Area
2.5.1.6.8 Switzerland
2.5.1.6.8.1 Market Overview by Product Type
2.5.1.6.8.2 Market Overview by Application Area
Reimbursement Proving to be a Major Setback
2.5.1.6.9 Portugal
2.5.1.6.9.1 Market Overview by Product Type
2.5.1.6.9.2 Market Overview by Application Area
Scenario in the Recent Past
2.5.1.6.10 Austria
2.5.1.6.10.1 Market Overview by Product Type
2.5.1.6.10.2 Market Overview by Application Area
2009 Vs. 2010
2.5.1.6.11 Greece
2.5.1.6.11.1 Market Overview by Product Type
2.5.1.6.11.2 Market Overview by Application Area
A Greek Tragedy
2.5.1.6.12 Scandinavia
2.5.1.6.12.1 Market Overview by Product Type
2.5.1.6.12.2 Market Overview by Application Area
2.5.1.6.13 Rest of Western Europe
2.5.1.6.13.1 Market Overview by Product Type
2.5.1.6.13.2 Market Overview by Application Area
2.5.2 Eastern Europe
2.5.2.1 Market Overview by Geographic Region
2.5.2.2 Market Overview by Product Type
2.5.2.3 Market Overview by Application Area
2.5.2.4 IVD Product Type Overview by Eastern Europe Region
2.5.2.4.1 Reagents & Consumables
2.5.2.4.2 Instruments & Systems
2.5.2.5 IVD Application Area Overview by Eastern Europe Region
2.5.2.5.1 Clinical Chemistry
2.5.2.5.2 Immunoassay
2.5.2.5.3 Diabetes Testing
2.5.2.5.4 Blood Testing
2.5.2.5.5 Molecular Diagnostics
2.5.2.5.6 Pathology
2.5.2.5.7 Cellular Analysis
2.5.2.5.8 Microbiology
2.5.2.6 Eastern Europe Market Overview by Country
2.5.2.6.1 Poland
2.5.2.6.1.1 Market Overview by Product Type
2.5.2.6.1.2 Market Overview by Application Area
2.5.2.6.2 Czech Republic
2.5.2.6.2.1 Market Overview by Product Type
2.5.2.6.2.2 Market Overview by Application Area
2.5.2.6.3 Russia
2.5.2.6.3.1 Market Overview by Product Type
2.5.2.6.3.2 Market Overview by Application Area
2.5.2.6.4 Rest of Eastern Europe
2.5.2.6.4.1 Market Overview by Product Type
2.5.2.6.4.2 Market Overview by Application Area
3. ASIA-PACIFIC
3.1 Market Overview by Geographic Region
3.2 Market Overview by Product Type
3.3 Market Overview by Application Area
3.4 IVD Product Type Overview by Asia-Pacific Region
3.4.1 Reagents & Consumables
3.4.2 Instruments & Systems
3.5 IVD Application Area Overview by Asia-Pacific Region
3.5.1 Clinical Chemistry
3.5.2 Immunoassay
3.5.3 Diabetes Testing
3.5.4 Blood Testing
3.5.5 Molecular Diagnostics
3.5.6 Pathology
3.5.7 Cellular Analysis
3.5.8 Microbiology
3.6 Major Market Players
Arkray, Inc. (Japan)
China Medical Technologies, Inc. (China)
Kaneka Corporation (Japan)
Olympus Corporation (Japan)
Shanghai Kehua Bio-Engineering (China)
Sysmex Corporation (Japan)
3.7 Asia-Pacific Market Overview by Country
3.7.1 Japan
3.7.1.1 Market Overview by Product Type
3.7.1.2 Market Overview by Application Area
3.7.2 China
3.7.2.1 Market Overview by Product Type
3.7.2.2 Market Overview by Application Area
3.7.3 India
3.7.3.1 Market Overview by Product Type
3.7.3.2 Market Overview by Application Area
3.7.4 Rest of Asia-Pacific
3.7.4.1 Market Overview by Product Type
3.7.4.2 Market Overview by Application Area
4. SOUTH AMERICA
4.1 Market Overview by Geographic Region
4.2 Market Overview by Product Type
4.3 Market Overview by Application Area
4.4 IVD Product Type Overview by South American Region
4.4.1 Reagents & Consumables
4.4.2 Instruments & Systems
4.5 IVD Application Area Overview by South American Region
4.5.1 Clinical Chemistry
4.5.2 Immunoassay
4.5.3 Diabetes Testing
4.5.4 Blood Testing
4.5.5 Molecular Diagnostics
4.5.6 Pathology
4.5.7 Cellular Analysis
4.5.8 Microbiology
4.6 South American Market Overview by Country
4.6.1 Argentina
4.6.1.1 Market Overview by Product Type
4.6.1.2 Market Overview by Application Area
4.6.2 Brazil
4.6.2.1 Market Overview by Product Type
4.6.2.2 Market Overview by Application Area
4.6.3 Rest of South America
4.6.3.1 Market Overview by Product Type
4.6.3.2 Market Overview by Application Area
5. REST OF WORLD
5.1 Market Overview by Product Type
5.2 Market Overview by Application Area
PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
1.1 Canada
1.2 United States
2. EUROPE
2.1 Belgium
2.2 Denmark
2.3 Finland
2.4 France
2.5 Germany
2.6 Ireland
2.7 Italy
2.8 Norway
2.9 Spain
2.10 Sweden
2.11 Switzerland
2.12 The Netherlands
2.13 United Kingdom
3. ASIA-PACIFIC
3.1 Australia
3.2 China
3.3 Hong Kong
3.4 Japan
3.5 Malaysia
3.6 New Zealand
3.7 Singapore
3.8 South Korea
3.9 Thailand
4. REST OF WORLD
4.1 Israel
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. THE QUESTIONNAIRE
3. FEEDBACK
Charts & Graphs
PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Classification of IVD Reagents and Instruments by Application Area
Chart 2: Global IVD Market (2012 & 2018) in Clinical Chemistry Applications by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 3: Global IVD Market (2012 & 2018) in Immunoassay Applications by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 4: Global IVD Market (2012 & 2018) in Diabetes Testing Applications by Geographic Region – North America, 7Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 5: Global IVD Market (2012 & 2018) in Blood Testing Applications by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 6: Global IVD Market (2012 & 2018) in Molecular Diagnostics Applications by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 7: Global IVD Market (2012 & 2018) in Pathology Applications by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 8: Global IVD Market (2012 & 2018) in Microbiology Applications by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 9: Global In Vitro Diagnostics Market Analysis (2008-2018) in USD Million
Chart 10: Global In Vitro Diagnostics Market Analysis (2008-2018) by Product Type – Reagents & Consumables and Instruments & Systems in USD Million
Chart 11: Glance at 2008, 2013 and 2018 Global In Vitro Diagnostics Market Share (%) by Product Type – Reagents & Consumables and Instruments & Systems
Chart 12: Global In Vitro Diagnostics Market Analysis (2008-2018) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
Chart 13: Glance at 2008, 2013 and 2018 Global In Vitro Diagnostics Market Share (%) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
Chart 14: Global IVD Reagents & Consumables Market Analysis (2008-2018) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 15: Glance at 2008, 2013 and 2018 Global IVD Reagents & Consumables Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 16: Global IVD Instruments & Systems Market Analysis (2008-2018) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 17: Glance at 2008, 2013 and 2018 Global IVD Instruments & Systems Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 18: Global IVD Market Analysis in Clinical Chemistry Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 19: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Clinical Chemistry by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 20: Global IVD Market Analysis in Immunoassay Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 21: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Immunoassay by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 22: Global IVD Market Analysis in Diabetes Testing Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 23: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Diabetes Testing by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 24: Global IVD Market Analysis in Blood Testing Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 25: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Blood Testing by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 26: Global IVD Market Analysis in Molecular Diagnostics Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 27: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Molecular Diagnostics by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 28: Global IVD Market Analysis in Pathology Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 29: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Pathology by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 30: Global IVD Market Analysis in Cellular Analysis Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 31: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Cellular Analysis by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 32: Global IVD Market Analysis in Microbiology Applications (2008-2018) Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 33: Glance at 2008, 2013 and 2018 Global Market Share (%) of IVD in Microbiology by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
PART B: REGIONAL MARKET PERSPECTIVE
Chart 34: The Projection of Largest Regions in terms of Market Growth for In Vitro Diagnostics by Geography – Asia-Pacific, South America, North America and Europe
Chart 35: Global In Vitro Diagnostics Market Analysis (2008-2018) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 36: Glance at 2008, 2013 and 2018 Global In Vitro Diagnostics Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
REGIONAL MARKET OVERVIEW
NORTH AMERICA
Chart 37: North American In Vitro Diagnostics Market Analysis (2008-2018) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 38: Glance at 2008, 2013 and 2018 North American In Vitro Diagnostics Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 39: North American In Vitro Diagnostics Market Analysis (2008-2018) by Product Type – Reagents & Consumables and Instruments & Systems in USD Million
Chart 40: Glance at 2008, 2013 and 2018 North American In Vitro Diagnostics Market Share (%) by Product Type – Reagents & Consumables and Instruments & Systems
Chart 41: North American In Vitro Diagnostics Market Analysis (2008-2018) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
Chart 42: Glance at 2008, 2013 and 2018 North American In Vitro Diagnostics Market Share (%) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
Chart 43: North American IVD Reagents & Consumables Market Analysis (2008-2018) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 44: Glance at 2008, 2013 and 2018 North American IVD Reagents & Consumables Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 45: North American IVD Instruments & Systems Market Analysis (2008-2018) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 46: Glance at 2008, 2013 and 2018 North American IVD Instruments & Systems Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 47: North American IVD Market Analysis in Clinical Chemistry Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 48: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Clinical Chemistry by Geographic Region – United States, Canada and Mexico
Chart 49: North American IVD Market Analysis in Immunoassay Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 50: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Immunoassay by Geographic Region – United States, Canada and Mexico
Chart 51: North American IVD Market Analysis in Diabetes Testing Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 52: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Diabetes Testing by Geographic Region – United States, Canada and Mexico
Chart 53: North American IVD Market Analysis in Blood Testing Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 54: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Blood Testing by Geographic Region – United States, Canada and Mexico
Chart 55: North American IVD Market Analysis in Molecular Diagnostics Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 56: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Molecular Diagnostics by Geographic Region – United States, Canada and Mexico
Chart 57: North American IVD Market Analysis in Pathology Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 58: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Pathology by Geographic Region – United States, Canada and Mexico
Chart 59: North American IVD Market Analysis in Cellular Analysis Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 60: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Cellular Analysis by Geographic Region – United States, Canada and Mexico
Chart 61: North American IVD Market Analysis in Microbiology Applications (2008-2018) Geographic Region – United States, Canada and Mexico in USD Million
Chart 62: Glance at 2008, 2013 and 2018 North American Market Share (%) of IVD in Microbiology by Geographic Region – United States, Canada and Mexico
United States
Chart 63: United States In Vitro Diagnostics Market Analysis (2008-2018) by Product Type – Reagents & Consumables and Instruments & Systems in USD Million
Chart 64: Glance at 2008, 2013 and 2018 United States In Vitro Diagnostics Market Share (%) by Product Type – Reagents & Consumables and Instruments & Systems
Chart 65: United States In Vitro Diagnostics Market Analysis (2008-2018) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
Chart 66: Glance at 2008, 2013 and 2018 United States In Vitro Diagnostics Market Share (%) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
Canada
Chart 67: Canadian In Vitro Diagnostics Market Analysis (2008-2018) by Product Type – Reagents & Consumables and Instruments & Systems in USD Million
Chart 68: Glance at 2008, 2013 and 2018 Canadian In Vitro Diagnostics Market Share (%) by Product Type – Reagents & Consumables and Instruments & Systems
Chart 69: Canadian In Vitro Diagnostics Market Analysis (2008-2018) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
Chart 70: Glance at 2008, 2013 and 2018 Canadian In Vitro Diagnostics Market Share (%) by Application Area – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
Mexico
Chart 71: Mexican In Vitro Diagnostics Market Analysis (2008-2018) by Pr
